Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist

Am J Med. 2012 Jun;125(6):e9-e10. doi: 10.1016/j.amjmed.2012.02.006. Epub 2012 Apr 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / immunology
  • Antitubercular Agents / therapeutic use*
  • Bronchoalveolar Lavage
  • Cough / microbiology
  • Drug Therapy, Combination
  • Fever / microbiology
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / diagnosis*
  • Lymph Nodes / microbiology*
  • Lymph Nodes / pathology
  • Male
  • Muscle Weakness / microbiology
  • Mycobacterium tuberculosis / isolation & purification*
  • Necrosis
  • Psoriasis / drug therapy
  • Tomography, X-Ray Computed
  • Tuberculosis, Pulmonary / diagnosis*
  • Tuberculosis, Pulmonary / diagnostic imaging
  • Tuberculosis, Pulmonary / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology
  • Weight Loss

Substances

  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab